Cronos Q2 2022 Revenue Grows 47% YoY, Company Focused On Rare Cannabinoids
Cronos Group Inc. (NASDAQ: CRON) (TSX:CRON) released its 2022 second quarter business results, revealing gross profit of $4.1 million in Q2 2022 improved by $19.9 million from Q2 2021.
